SCHEMBL12987397

SCHEMBL12987397

CCc1nc2nc3ccccc3c(=O)n2c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.51
ALDH1A1 P00352 6/20 0.51
HPGD P15428 4/20 0.51
HSD17B10 Q99714 3/20 0.51
MAPK1 P28482 3/20 0.51
LMNA P02545 2/20 0.51
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TP53 P04637 1/20 0.46
POLB P06746 1/20 0.45
MAPT P10636 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
PDE7A Q13946 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12987706 0.81 PDE4A (0.44) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL3547426 0.78 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL3549495 0.78 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL12987546 0.77 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL12987717 0.77 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL12987693 0.77 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL12987385 0.76 TNKS2 (0.40) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL12987105 0.74 PDE5A (0.39) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL12987766 0.73 USP2 (0.49) KDM4EALDH1A1HPGDHSD17B10MAPK1
SCHEMBL11823608 0.70 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7855214-B2 Fused cyclic systems useful as inhibitors of TEC family protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-21 US disclosed